Through substantial leadership turnover and workforce cuts, the FDA has continued to support the advanced therapy sector, ...

The current negative list restricts foreign investment in the development and application of human stem cells and gene ...

With a storied history in vaccine development, India's Bharat Biotech is shaking things up and answering the call of advanced therapeutics. Bharat has unveiled plans to set up its first cell and gene ...

Uniphar, a global leader in pharmaceutical and medtech solutions has announced the launch of its 10th cell and gene therapy (CGT) project. The milestone reinforces Uniphar’s commitment to ensuring ...

Tozaro, based in Bedford, U.K., formed a technical advisory board (TAB) to provide strategic guidance around commercialization and further development of the company’s smart polymer platform for ...

Q3 2025 Management View CEO Jerrell Shelton highlighted double-digit growth in both Life Sciences Services and Life Sciences Product segments, noting "revenue from our support of commercial cell and ...

A new West Coast biotech has emerged into the busy in vivo cell therapy space, this time with the backing of Nobel Prize-winning CRISPR pioneer Jennifer Doudna, Ph.D. Azalea Therapeutics has bloomed ...

The FDA’s approval in December of a new gene editing treatment for sickle cell disease not only represents a potential cure for a painful illness that afflicts millions of people globally but could be ...

The FDA has put a clinical hold on a Tenaya Therapeutics gene therapy study | The FDA has put a clinical hold on a Tenaya ...

UCSF Benioff Children’s Hospital Oakland is enrolling patients in an innovative clinical trial that seeks to cure sickle cell disease. The trial is the first in the U.S. to apply non-viral CRISPR-Cas9 ...